Changing the treatment paradigm for type 2 diabetes

Diabetes Care. 2009 Nov;32 Suppl 2(Suppl 2):S217-22. doi: 10.2337/dc09-S314.

Authors

Stefano Del Prato¹, Giuseppe Penno, Roberto Miccoli

Affiliation

¹ Department of Endocrinology and Metabolism, Section of Metabolic Diseases and Diabetes, University of Pisa, Pisa, Italy. delprato@immr.med.unipi.it

No abstract available

Publication types

Review

MeSH terms

Algorithms
Blood Glucose / metabolism*
Delivery of Health Care / standards
Diabetes Mellitus, Type 2 / blood
Diabetes Mellitus, Type 2 / complications
Diabetes Mellitus, Type 2 / drug therapy
Diabetes Mellitus, Type 2 / therapy*
Diabetic Angiopathies / prevention & control
Diabetic Angiopathies / therapy
Exercise
Humans
Hyperglycemia / prevention & control
Hypoglycemic Agents / therapeutic use
Life Style
Metformin / therapeutic use
Patient Education as Topic
Risk Reduction Behavior

Substances

Blood Glucose
Hypoglycemic Agents
Metformin